Related Experiment Video
Updated: Jul 3, 2026
05:54
MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Central nervous system-directed effects of FTY720 (fingolimod)
Veronique E Miron1, Anna Schubart, Jack P Antel
1Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4. veronique.miron@mcgill.ca
Journal of the Neurological Sciences
|August 6, 2008
Summary
Fingolimod (FTY720), an S1P analogue, shows neuroprotective effects in multiple sclerosis models, potentially acting directly within the central nervous system. Further research is needed to clarify its direct and indirect impacts across the MS spectrum.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system (CNS).
- Current MS therapies primarily target the systemic immune system.
- Fingolimod (FTY720) is an orally administered sphingosine-1-phosphate (S1P) analogue investigated for both relapsing-remitting (RR) and progressive MS.
Purpose of the Study:
- To investigate the potential direct effects of fingolimod (FTY720) on the central nervous system (CNS) in multiple sclerosis (MS).
- To evaluate the neuroprotective capabilities of FTY720 beyond its known immunomodulatory actions.
Main Methods:
- In vitro studies assessing dose-dependent effects on neural cell survival, differentiation, and cytoskeletal dynamics.
- Experimental autoimmune encephalomyelitis (EAE) animal model studies to evaluate neuroprotection.
Main Results:
- FTY720 demonstrated dose-dependent effects on neural cell survival and differentiation in vitro.
- EAE studies indicated an overall neuroprotective effect of FTY720, partly mediated by CNS actions.
- FTY720's lipophilic nature allows it to cross the blood-brain barrier (BBB), suggesting direct CNS activity.
Conclusions:
- FTY720 may exert direct beneficial effects on CNS cells, including neurons, oligodendrocytes, and glial cells.
- Understanding FTY720's direct CNS effects is crucial for optimizing its use across the spectrum of MS.
- Further research is required to delineate the precise mechanisms of FTY720's action within the CNS.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...